Facility overview video: Deeside, UK

14th Mar 2024

At Sterling, our integrated global facilities enable us to support a broad range of project requirements for our customers, primarily for small molecule API and ADC development and manufacturing.

Welcome to our Deeside, Wales, UK site, which specialises in the discovery, development and clinical manufacture of antibody-drug conjugates.

Let’s focus on five things you should know about our Deeside facility.

The Deeside facility delivers comprehensive bioconjugation services. With purpose-built facilities and a specialised team, the site is wholly focused on supporting complex bioconjugation programmes.

The Deeside site is licensed for clinical GMP manufacturing. With certified Grade C and D manufacturing environments, the site is equipped to accommodate manufacture for all clinical trial phases, GMP release testing and stability studies.

The Deeside site delivers extensive analytical expertise. With specialised capabilities in mass spectrometry, chromatography, bioassays and more, the analytical team supports a range of analytical and quality control services optimised for bioconjugation programmes.

The Deeside facility is designed for hazard banding 5 containment. Our team can safely handle highly potent and cytotoxic materials, while fully customised containment measures to a project’s specific requirements.

Finally, the team at Deeside has experience working with a wide variety of targeting molecules, linkers, toxins, and conjugation chemistries. By combining our expertise with support from Sterling’s Wisconsin and North Carolina, US sites to manufacture linker payloads, we work in partnership with our customers to develop custom ADCs for a desired therapeutic outcome.

Sterling’s Deeside team pairs excellence in bioconjugation with close customer collaboration to successfully deliver ADC projects for our customers.

Related Content


Antibody drug conjugates (ADC): The magic bullets


Antibody drug conjugates (ADCs) at Sterling


Harnessing analytical chemistry in ADC development

Poster Presentation

Mass spectrometry as a tool in ADC development


Phase I ADC development and manufacturing: A case study